Alexander Kulagin Selected Research

Acute Myeloid Leukemia (Acute Myelogenous Leukemia)

5/2024	Posttransplant cyclophosphamide versus anti-thymocyte globulin versus combination for graft-versus-host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party.
4/2024	Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
1/2023	Allogeneic stem cell transplantation for patients with acute myeloid leukemia (AML) in second complete remission (CR2) transplanted from unrelated donors with post-transplant cyclophosphamide (PTCy). A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
1/2023	Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT.
11/2022	Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia.
11/2022	Correction: Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexander Kulagin Research Topics

Disease

7	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2024 - 01/2023
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 11/2022
5	Leukemia 05/2024 - 11/2022
4	Aplastic Anemia (Anemia, Hypoplastic) 04/2024 - 03/2010
4	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 03/2024 - 09/2022
2	Bronchiolitis Obliterans Syndrome 01/2023 - 08/2021
2	idiopathic Aplastic anemia 01/2023 - 01/2022
2	Hodgkin Disease (Hodgkin's Disease) 09/2022 - 11/2021
1	Pathologic Complete Response 05/2024
1	Infections 04/2024
1	WHIM syndrome 04/2024
1	Hematologic Neoplasms (Hematological Malignancy) 03/2024
1	Hemolysis 01/2023
1	Communicable Diseases (Infectious Diseases) 01/2023
1	Rare Diseases (Rare Disease) 01/2023
1	COVID-19 01/2023
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022
1	Fatigue 09/2022
1	Wiskott-Aldrich Syndrome 01/2022
1	Disease Progression 11/2021
1	Pure Red-Cell Aplasia 11/2019
1	Pancytopenia 04/2008
1	Multiple Myeloma 04/2008

Drug/Important Bio-Agent (IBA)

9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2024 - 09/2022
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 05/2024 - 01/2024
3	Calcineurin InhibitorsIBA 04/2024 - 01/2023
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2024 - 04/2008
2	ravulizumabIBA 03/2024 - 09/2022
2	Complement Inactivating AgentsIBA 01/2023 - 09/2022
1	mavorixaforIBA 04/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2024
1	Tacrolimus (Prograf)FDA LinkGeneric 04/2024
1	Methotrexate (Mexate)FDA LinkGeneric 04/2024
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 04/2024
1	AntigensIBA 03/2024
1	SteroidsIBA 01/2023
1	Prostaglandins FIBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Biosimilar PharmaceuticalsIBA 01/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	fludarabineIBA 09/2022
1	Complement C5 (Complement 5)IBA 09/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2022
1	Bendamustine Hydrochloride FDA Link 09/2022
1	eculizumab FDA Link 09/2022
1	Immune Checkpoint InhibitorsIBA 11/2021
1	Alemtuzumab (Campath)FDA Link 03/2010

Therapy/Procedure

10	Transplantation 05/2024 - 11/2022
9	Hematopoietic Stem Cell Transplantation 01/2023 - 08/2021
6	Stem Cell Transplantation 05/2024 - 11/2019
3	Haploidentical Transplantation 05/2024 - 11/2022
2	Homologous Transplantation 04/2024 - 01/2023
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022
1	Immunotherapy 11/2021
1	Therapeutics 11/2021
1	Photopheresis 08/2021